Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Oil Fund LP
USO
No Data
Quest Receives Cash Dividend Payment From OncoQuest
Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis
Oregovomab Phase III Clinical Study Fails Futility Analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits